Intra-Cellular Therapies Statistics
Total Valuation
FRA:BAYN has a market cap or net worth of EUR 25.26 billion. The enterprise value is 68.11 billion.
Market Cap | 25.26B |
Enterprise Value | 68.11B |
Important Dates
The last earnings date was Wednesday, August 6, 2025.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | Apr 28, 2025 |
Share Statistics
Current Share Class | 982.42M |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.07% |
Shares Change (QoQ) | +1.28% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 5.48 |
PS Ratio | 0.55 |
PB Ratio | 0.70 |
P/TBV Ratio | n/a |
P/FCF Ratio | 5.50 |
P/OCF Ratio | 3.53 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.55, with an EV/FCF ratio of 14.83.
EV / Earnings | -19.93 |
EV / Sales | 1.48 |
EV / EBITDA | 9.55 |
EV / EBIT | 17.49 |
EV / FCF | 14.83 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 1.30.
Current Ratio | 1.27 |
Quick Ratio | 0.66 |
Debt / Equity | 1.30 |
Debt / EBITDA | 6.29 |
Debt / FCF | 10.14 |
Interest Coverage | 3.55 |
Financial Efficiency
Return on equity (ROE) is -9.51% and return on invested capital (ROIC) is 3.16%.
Return on Equity (ROE) | -9.51% |
Return on Assets (ROA) | 2.17% |
Return on Invested Capital (ROIC) | 3.16% |
Return on Capital Employed (ROCE) | 4.72% |
Revenue Per Employee | 508,049 |
Profits Per Employee | -37,608 |
Employee Count | 91,864 |
Asset Turnover | 0.39 |
Inventory Turnover | 1.51 |
Taxes
Income Tax | -16.00M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.53% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -1.53% |
50-Day Moving Average | 27.07 |
200-Day Moving Average | 23.22 |
Relative Strength Index (RSI) | 39.54 |
Average Volume (20 Days) | 3,206,615 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:BAYN had revenue of EUR 46.17 billion and -3.42 billion in losses. Loss per share was -3.48.
Revenue | 46.17B |
Gross Profit | 26.44B |
Operating Income | 4.17B |
Pretax Income | -3.42B |
Net Income | -3.42B |
EBITDA | 7.05B |
EBIT | 4.17B |
Loss Per Share | -3.48 |
Balance Sheet
The company has 3.89 billion in cash and 46.58 billion in debt, giving a net cash position of -42.69 billion.
Cash & Cash Equivalents | 3.89B |
Total Debt | 46.58B |
Net Cash | -42.69B |
Net Cash Per Share | n/a |
Equity (Book Value) | 35.85B |
Book Value Per Share | 35.87 |
Working Capital | 8.58B |
Cash Flow
In the last 12 months, operating cash flow was 7.15 billion and capital expenditures -2.56 billion, giving a free cash flow of 4.59 billion.
Operating Cash Flow | 7.15B |
Capital Expenditures | -2.56B |
Free Cash Flow | 4.59B |
FCF Per Share | n/a |
Margins
Gross margin is 57.26%, with operating and profit margins of 9.03% and -7.40%.
Gross Margin | 57.26% |
Operating Margin | 9.03% |
Pretax Margin | -7.42% |
Profit Margin | -7.40% |
EBITDA Margin | 15.27% |
EBIT Margin | 9.03% |
FCF Margin | 9.95% |
Dividends & Yields
This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 0.44%.
Dividend Per Share | 0.11 |
Dividend Yield | 0.44% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.07% |
Shareholder Yield | 0.51% |
Earnings Yield | -13.53% |
FCF Yield | 18.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on June 3, 1996. It was a forward split with a ratio of 10.
Last Split Date | Jun 3, 1996 |
Split Type | Forward |
Split Ratio | 10 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |